Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07534878Phase 4Completed
Phase 4, open-label, single-arm trial in functional decline in older adults and Mild Cognitive Impairment (MCI), sponsored by Gplife Healthcare. Primary endpoint: 6-minute walk test at Week 8. Started Dec 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07534878.